Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina

Journal of Clinical Microbiology

Volumn 44, Issue 1, 2006, Pages 192-200

  Sola, Claudia ^a   Cortes, Paulo ^a   Saka, Hector A ^a   Vindel, Ana ^b   Bocco, José Luis ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENOMIC DNA; GENTAMICIN; KANAMYCIN; LINCOSAMIDE; MACROLIDE; METICILLIN; MIKAMYCIN B; MINOCYCLINE; NETILMICIN; NITROFURANTOIN; OXACILLIN; PENICILLIN DERIVATIVE; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLONE; EPIDEMIC; EVOLUTION; GENOTYPE; HOSPITAL INFECTION; MEC GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPAA GENE; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; ARGENTINA; BACTERIAL TYPING TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EVOLUTION, MOLECULAR; HOSPITALS; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 30744471694     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.1.192-200.2006     Document Type: Article

References (45)

1. Aires de Sousa, M., C. Bartzavali, I. Spiliopoulou, I. S. Sanches, M. I. Crisóstomo, and H. de Lencastre. 2003. Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J. Clin. Microbiol. 41:2027-2032.
2. Aires de Sousa, M., and H. de Lencastre. 2003. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J. Clin. Microbiol. 41:3806-3815.
3. Amorim, M. L., M. Aires de Sousa, I. S. Sanches, R. Sa-Leao, J. M. Cabeda, J. M. Amorim, and H. de Lencastre. 2002. Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time. Microb. Drug Resist. 8:301-309.
4. Bantar, C., A. Famiglietti, M. Goldberg, et al. 2000. Three-year surveillance study of nosocomial bacterial resistance in Argentina. Int. J. Infect. Dis. 4:85-90.
5. Bantar, C., A. Famiglietti, M. Radice, et al. Comparative analysis during two periods of prevalence from 1999 to 2003. Bulletins 144, 153, 158, and 167. (In Spanish.) Asociacion Argentina de Microbiologia, Buenos Aires, Argentina. [Online.] http://www.aam.org.ar/archivos/167_SIR.pdf.
6. Berglund, C., P. Molling, L. Sjoberg, and B. Soderquist. 2005. Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin. Microbiol. Infect. 11:447-456.
7. Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182.
8. Denis, O., A. Deplano, C. Nonhoff, R. De Ryck, R. de Mendonca, S. Rottiers, R. Vanhoof, and M. J. Struelens. 2004. National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones. Antimicrob. Agents Chemother. 48:3625-3629.
9. Ender, M., N. McCallum, R. Adhikari, and B. Berger-Bächi. 2004. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:2295-2297.
10. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
11. Enright, M. C., D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99:7687-7692.
12. Feil, E. J., J. E. Cooper, H. Grundmann, D. A. Robinson, M. C. Enright, T. Berendt, S. J. Peacock, J. M. Smith, M. Murphy, B. G. Spratt, C. E. Moore, and N. P. Day. 2003. How clonal is Staphylococcus aureus? J. Bacteriol. 185:3307-3316.
13. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
14. Howe, R. A., A. Monk, M. Wootton, T. R. Walsh, and M. C. Enright. 2004. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 10:855-857.
15. Hubert, S. K., J. M. Mohammed, S. K. Fridkin, R. P. Gaynes, J. E. McGowan, Jr., and F. C. Tenover. 1999. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J. Clin. Microbiol. 37:3590-3593.
16. Ida, T., R. Okamoto, C. Shimauchi, T. Okubo, A. Kuga, and M. Inoue. 2001. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J. Clin. Microbiol. 39:3115-3121.
17. Ito, T., X. X. Ma, F. Takeuchi, K. Okuma, H. Yuzawa, and K. Hiramatsu. 2004. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother. 48:2637-2651.
18. Ito, T., K. Okuma, X. X. Ma, H. Yuzawa, and K. Hiramatsu. 2003. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist. Updates 6:41-52.
19. Kerr, S., G. E. Kerr, C. A. Mackintosh, and R. R. Marples. 1990. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J. Hosp. Infect. 16:35-48.
20. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
21. Lescat, M., C. Dupeyron, E. Faubert, and N. Mangeney. 2004. Pulse-field gel electrophoresis typing of methicillin-resistant Staphylococcus aureus strains susceptible to aminoglycosides isolated from 1993 to 2002. J. Hosp. Infect. 57:253-257.
22. Ma, X. X., A. Galiana, W. Pedreira, M. Mowszowicz, I. Christophersen, S. Machiavello, L. Lope, S. Benaderet, F. Buela, W. Vincentino, M. Albini, O. Bertaux, I. Constenla, H. Bagnulo, L. Llosa, T. Ito, and K. Hiramatsu. 2005. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg. Infect. Dis. 11:973-976.
23. Melter, O., M. Aires de Sousa, P. Urbaskova, V. Jakubu, H. Zemlickova, and H. de Lencastre. 2003. Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J. Clin. Microbiol. 41:4998-5005.
24. Murchan, S., M. E. Kaufmann, A. Deplano, R. de Ryck, M. Struelens, C. E. Zinn, V. Fussing, S. Salmenlinna, J. Vuopio-Varkila, N. El Solh, C. Cuny, W. Witte, P. T. Tassios, N. Legakis, W. van Leeuwen, A. van Belkum, A. Vindel, I. Laconcha, J. Garaizar, S. Haeggman, B. Olsson-Liljequist, U. Ransjo, G. Coombes, and B. Cookson. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:1574-1585.
25. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing. M100-S11. Eleventh informational supplement. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 5th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
27. Nimmo, G. R., J. Schooneveldt, G. O'Kane, B. McCall, and A. Vickery. 2000. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J. Clin. Microbiol. 38:3926-3931.
28. O'Brien, F. G., T. T. Lim, F. N. Chong, G. W. Coombs, M. C. Enright, D. A. Robinson, A. Monk, B. Said-Salim, B. N. Kreiswirth, and W. B. Grubb. 2004. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J. Clin. Microbiol. 42:3185-3190.
29. Okuma, K., K. Iwakawa, J. D. Turnidge, W. B. Grubb, J. M. Bell, F. G. O'Brien, G. W. Coombs, J. W. Pearman, F. C. Tenover, M. Kapi, C. Tiensasitorn, T. Ito, and K. Hiramatsu. 2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40:4289-4294.
30. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
31. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2001. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb. Drug Resist. 7:349-361.
32. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.
33. O'Neill, G. L., S. Murchan, A. Gil-Setas, and H. M. Aucken. 2001. Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J. Clin. Microbiol. 39:1540-1548.
34. Robinson, D. A., and M. C. Enright 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.
35. Shopsin, B., M. Gomez, S. O. Montgomery, D. H. Smith, M. Waddington, D. E. Dodge, D. A. Bost, M. Riehman, S. Naidich, and B. N. Kreiswirth. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556-3563.
36. Shore, A., A. S. Rossney, C. T. Keane, M. C. Enright, and D. C. Coleman. 2005. Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob. Agents Chemother. 49:2070-2083.
37. Sola, C., G. Gribaudo, Córdoba MRSA Collaborative Study Group, A. Vindel, L. Patrito, and J. L. Bocco. 2002. Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Cordoba, Argentina, involved in nosocomial infections. J. Clin. Microbiol. 40:1427-1435.
38. Talon, D., E. Deliere, and X. Bertrand. 2002. Characterization of methicillin-resistant Staphylococcus aureus strains susceptible to tobramycin. Int. J. Antimicrob. Agents 20:174-179.
39. Tenover, F. C., R. D. Arbeit, R. V. Goering, et al. 1997. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect. Control Hosp. Epidemiol. 18:426-439.
40. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
41. Tenover, F. C., J. W. Biddle, and M. V. Lancaster. 2001. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7:327-332.
42. Thouverez, M., A. Muller, D. Hocquet, D. Talon, and X. Bertrand. 2003. Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital. J. Med. Microbiol. 52:801-806.
43. Velazquez-Meza, M. E., M. Aires de Sousa, G. Echaniz-Aviles, F. Solorzano-Santos, G. Miranda-Novales, J. Silva-Sanchez, and H. de Lencastre. 2004. Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997 to 2003): clonal evolution and impact of infection control. J. Clin. Microbiol. 42:3877-3880.
44. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
45. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.